Xiwang Pharmaceutical processes 3 million tons of corn annually and is equipped with advanced corn processing production lines. We also possesses a corn fructose production line that has mastered core technologies and achieved large-scale production in China. Additionally, we holds five drug approval numbers.
Since our establishment, Xiwang Pharmaceutical has always taken the development of China's starch sugar as its mission, actively strengthening and expanding our main business of corn deep processing. we have developed a circular economy model featuring raw material recycling and hierarchical product development in corn deep processing. The enterprise has also developed more than 20 high-tech technologies such as the "continuous crystallization in horizontal crystallizer", and our production processes and technological equipment are at the leading level in the industry.
